A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news ...

has announced the publication of a review in the Journal of Nephrological Science that explores patient perspectives on phosphate management in chronic kidney disease (CKD). The review highlights ...